Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...
Cardiovascular disease remains the leading cause of mortality worldwide, necessitating deeper insights into its molecular ...
A new study has uncovered how an exceptionally scarce protein can orchestrate the assembly of large-scale gene-silencing structures inside cells, and what happens when that process breaks down. The ...
Post-traumatic osteoarthritis develops rapidly after joint injury, yet current treatments largely address symptoms rather ...
A research group led by Associate Professor Tetsuya Muramoto from the Faculty of Science, Toho University, has established a CRISPR genome editing technique that enables comparative analysis of the ...
Researchers have developed a synthetic biological strategy to enable Clostridium sporogenes to thrive in the low oxygen ...
A new study has uncovered how an exceptionally scarce protein can orchestrate the assembly of large‑scale gene-silencing ...
News-Medical.Net on MSN
Study sheds light on potential therapeutic strategies for post-traumatic osteoarthritis
Post-traumatic osteoarthritis often affects younger, active individuals and progresses quickly following ligament or cartilage injury. Chondrocytes, the sole cell type in articular cartilage, survive ...
Nemours Children’s Hospital is now a qualified treatment center to offer a transformative gene therapy to treat sickle cell disease.
A new study discovers how nitric oxide triggers a biochemical domino effect in the brain, leading to mTOR overactivation in ...
Clinical Trials Arena on MSN
FDA releases hold on second of Intellia’s ATTR-CM gene therapy trials
Two Phase III trials were put on clinical hold by the FDA in October 2025.
Plants are constantly exposed to a wide array of biotic and abiotic stresses in their natural environments, posing ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果